News

Lung damage patterns on CT scans may differ by ANCA, AAV types

People with ANCA-associated vasculitis (AAV) may present different lung involvement patterns depending on the type of disease and self-reactive antibodies driving the disease, according to a small study. Given that “the type of pulmonary involvement in AAV is important to predict prognosis and mortality as well as for treatment…

Low dose of corticosteroids as good as high dose for AAV: Study

A low dose of intravenous or into-the-vein methylprednisolone, a corticosteroid, is as safe and effective as a high dose at preserving kidney function and extending survival in people with severe ANCA-associated vasculitis (AAV), a U.K. study found. Given that corticosteroids, a standard AAV treatment, are associated with significant…

Fasenra fares no worse than Nucala at keeping EGPA in remission

AstraZeneca’s Fasenra (benralizumab) — approved for a rare type of asthma — does no worse than Nucala (mepolizumab) at keeping eosinophilic granulomatosis with polyangiitis (EGPA) in remission. These are the first findings of the head-to-head Phase 3 MANDARA clinical trial (NCT04157348) that showed the study met its…